The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: Rockhard Weekend, Pandora, Fruta Planta

    FDA has received reports of adverse events associated with the use of Fruta Planta, including several cardiac events and one death.

    In addition, FDA testing revealed that certain lots of RockHard Weekend and Pandor contain an analogue of sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction.

    Fruta Planta poses a threat to consumers because sibutramine (Meridia) is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

    Sibutramine is a controlled substance that was withdrawn from the market in October 2010 for safety reasons.

    The active drug ingredient (sildenafil) isn’t listed on the labels of RockHard Weekend and Pandor. The lot numbers of affected products are listed here.

    The bottom line?

    Consumers should stop using these products and throw them away.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

    12/23/10 22:26 JR

    Leave a Comment

    You must be logged in to post a comment.